ResearcherMayo ClinicActive in the last 2 years
Vuong N. Trieu
Matched on ORCID iD 0000-0002-6675-0811; OpenAlex author ID A5059615305. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 3 papers
Papers 6
- TGFB2 Gene Methylation in Tumors with Low CD8+ T-Cell Infiltration Drives Positive Prognostic Overall Survival Responses in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms26125567↗
- TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients. Last author DOI 10.3390/ijms26136357↗
- Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter. Last author DOI 10.3390/ijms262411920↗
- TGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Surviv… First author DOI 10.3390/ijms252011221↗
- Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer. Last author DOI 10.2147/ott.s161905↗
- Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. Co-author DOI 10.1200/jco.2011.36.5742↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sanjive Qazi · 3 shared papers, 2025 · strength 0.93
- Paper TGFB2 Gene Methylation in Tumors with Low CD8+ T-Cell Infiltration Drives Positive Prognostic Overall Survival Response… DOI 10.3390/ijms26125567↗
- Paper TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients. DOI 10.3390/ijms26136357↗
- Paper Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter. DOI 10.3390/ijms262411920↗
- Sanjive Qazi · 1 shared paper, 2024 · strength 0.46
- Muhammad Wasif Saif · 1 shared paper, 2025 · strength 0.30
- Wen-Han Chang · 1 shared paper, 2025 · strength 0.30
- Osmond J. D’Cruz · 1 shared paper, 2018 · strength 0.11
- Mitesh J. Borad · 1 shared paper, 2011 · strength 0.02
- N.V. Rajeshkumar · 1 shared paper, 2011 · strength 0.02
- Patrick Soon‐Shiong · 1 shared paper, 2011 · strength 0.02
- Ronald Lee Korn · 1 shared paper, 2011 · strength 0.02
- Ramesh K. Ramanathan · 1 shared paper, 2011 · strength 0.02
- Manuel M. Hidalgo · 1 shared paper, 2011 · strength 0.02
- Anirban Maitra · 1 shared paper, 2011 · strength 0.02
- Daniel D. Von Hoff · 1 shared paper, 2011 · strength 0.02
- Daniel A. Laheru · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.